FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204138749> ?p ?o ?g. }

• W3204138749 endingPage "230" @default.
• W3204138749 startingPage "223" @default.
• W3204138749 abstract "Type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) are closely related, and antidiabetic medications have been shown to be potential therapeutics in NAFLD. Using a network meta-analysis, we sought to examine the effectiveness of antidiabetic agents for the treatment of NAFLD in patients with type 2 diabetes mellitus.Medline and Embase were searched for randomized controlled trials relating to the use of antidiabetic agents, including sodium-glucose transport protein 2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists, and peroxisome proliferator-activated receptor gamma (PPARγ) agonists, biguanides, sulfonylureas and insulin, on NAFLD in patients with diabetes. The p-score was used as a surrogate marker of effectiveness.A total of 14 articles were included in the analysis. PPARγ agonists were ranked as the best treatment in steatosis reduction, resulting in the greatest reduction of steatosis. There was statistical significance between PPARγ agonists [mean difference (MD): -6.02%, confidence interval (CI): -10.37% to -1.67%] and SGLT2 inhibitors (MD: -2.60%, CI: -4.87% to -0.33%) compared with standard of care for steatosis reduction. Compared with PPARγ agonists, SGLT2 inhibitors resulted in a statistical significant reduction in fibrosis (MD: -0.06, CI: -0.10 to -0.02). Body mass index reduction was highest in SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists. Additionally, SGLT2 inhibitors were ranked as the best treatment for increasing high-density lipoprotein and reducing low-density lipoprotein.Glucagon-like peptide-1 receptor agonists and SGLT2 inhibitors were suitable alternatives for the treatment of NAFLD in those with type 2 diabetes mellitus with a reduction in body mass index, fibrosis, and steatosis. SGLT2 inhibitors also have the added benefit of lipid modulation." @default.
• W3204138749 created "2021-10-11" @default.
• W3204138749 creator A5002624072 @default.
• W3204138749 creator A5004639766 @default.
• W3204138749 creator A5007912393 @default.
• W3204138749 creator A5009462555 @default.
• W3204138749 creator A5015041967 @default.
• W3204138749 creator A5026911776 @default.
• W3204138749 creator A5028905834 @default.
• W3204138749 creator A5030386760 @default.
• W3204138749 creator A5035309960 @default.
• W3204138749 creator A5040791928 @default.
• W3204138749 creator A5056064011 @default.
• W3204138749 creator A5058087480 @default.
• W3204138749 creator A5065179897 @default.
• W3204138749 creator A5075852881 @default.
• W3204138749 creator A5077629563 @default.
• W3204138749 creator A5080623484 @default.
• W3204138749 date "2022-02-01" @default.
• W3204138749 modified "2023-10-18" @default.
• W3204138749 title "Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials" @default.
• W3204138749 cites W1539916041 @default.
• W3204138749 cites W1814376565 @default.
• W3204138749 cites W1895758276 @default.
• W3204138749 cites W1964572117 @default.
• W3204138749 cites W1969489686 @default.
• W3204138749 cites W2010699829 @default.
• W3204138749 cites W2062812115 @default.
• W3204138749 cites W2063671857 @default.
• W3204138749 cites W2064387090 @default.
• W3204138749 cites W2080050561 @default.
• W3204138749 cites W2091106363 @default.
• W3204138749 cites W2113043745 @default.
• W3204138749 cites W2120397203 @default.
• W3204138749 cites W2127130842 @default.
• W3204138749 cites W2168763055 @default.
• W3204138749 cites W2170892587 @default.
• W3204138749 cites W2297000898 @default.
• W3204138749 cites W2519510391 @default.
• W3204138749 cites W2586902684 @default.
• W3204138749 cites W2625846788 @default.
• W3204138749 cites W2737083386 @default.
• W3204138749 cites W2742155329 @default.
• W3204138749 cites W2762936646 @default.
• W3204138749 cites W2764275027 @default.
• W3204138749 cites W2775026689 @default.
• W3204138749 cites W2788216507 @default.
• W3204138749 cites W2790481794 @default.
• W3204138749 cites W2808615577 @default.
• W3204138749 cites W2810643620 @default.
• W3204138749 cites W2810729752 @default.
• W3204138749 cites W2884734727 @default.
• W3204138749 cites W2888499775 @default.
• W3204138749 cites W2890539106 @default.
• W3204138749 cites W2896061464 @default.
• W3204138749 cites W2902244224 @default.
• W3204138749 cites W2907749909 @default.
• W3204138749 cites W2911721172 @default.
• W3204138749 cites W2916700999 @default.
• W3204138749 cites W2955615964 @default.
• W3204138749 cites W2970684805 @default.
• W3204138749 cites W2982675229 @default.
• W3204138749 cites W2990309084 @default.
• W3204138749 cites W2997878947 @default.
• W3204138749 cites W2999377366 @default.
• W3204138749 cites W3004139071 @default.
• W3204138749 cites W3004467589 @default.
• W3204138749 cites W3007475829 @default.
• W3204138749 cites W3007693094 @default.
• W3204138749 cites W3008837192 @default.
• W3204138749 cites W3019568499 @default.
• W3204138749 cites W3082461370 @default.
• W3204138749 cites W3084528742 @default.
• W3204138749 cites W3102426258 @default.
• W3204138749 cites W3118615836 @default.
• W3204138749 cites W3126030429 @default.
• W3204138749 cites W3127722099 @default.
• W3204138749 cites W3129584656 @default.
• W3204138749 cites W3132153535 @default.
• W3204138749 cites W3152705183 @default.
• W3204138749 cites W3154470597 @default.
• W3204138749 cites W3154897461 @default.
• W3204138749 cites W3155753566 @default.
• W3204138749 cites W3158749710 @default.
• W3204138749 cites W3166972534 @default.
• W3204138749 cites W3169894911 @default.
• W3204138749 cites W3174290103 @default.
• W3204138749 cites W3187380242 @default.
• W3204138749 cites W3194373099 @default.
• W3204138749 doi "https://doi.org/10.1016/j.eprac.2021.09.013" @default.
• W3204138749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34606980" @default.
• W3204138749 hasPublicationYear "2022" @default.
• W3204138749 type Work @default.
• W3204138749 sameAs 3204138749 @default.
• W3204138749 citedByCount "26" @default.
• W3204138749 countsByYear W32041387492021 @default.
• W3204138749 countsByYear W32041387492022 @default.
• W3204138749 countsByYear W32041387492023 @default.

• next